Oncoinvent ASA (OSL:ONCIN)
45.51
-0.49 (-1.05%)
Mar 30, 2026, 3:12 PM CET
Oncoinvent ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 75.39 | 133.67 | 30.1 | 196.02 | 292.03 | 113.3 |
Cash & Short-Term Investments | 75.39 | 133.67 | 30.1 | 196.02 | 292.03 | 113.3 |
Cash Growth | 150.49% | 344.15% | -84.65% | -32.88% | 157.76% | -4.26% |
Accounts Receivable | 1.05 | 0.45 | - | - | - | - |
Other Receivables | 5.37 | 5.38 | 21.5 | 13.48 | 15.13 | 12.64 |
Receivables | 6.43 | 5.83 | 21.5 | 13.48 | 15.13 | 12.64 |
Prepaid Expenses | - | 2.78 | 4.3 | 3.21 | - | - |
Restricted Cash | - | 2.03 | 2.03 | - | - | - |
Other Current Assets | 0 | -0 | - | - | - | 0.02 |
Total Current Assets | 81.81 | 144.3 | 57.92 | 212.71 | 307.16 | 125.96 |
Property, Plant & Equipment | 20.5 | 26.71 | 40.81 | 21.45 | 10.34 | 13.03 |
Other Long-Term Assets | 2.03 | 0 | - | - | - | - |
Total Assets | 104.34 | 171.02 | 98.73 | 234.16 | 317.5 | 138.99 |
Accounts Payable | 7.08 | 14.74 | 12.75 | 7.7 | 7.04 | 4.87 |
Accrued Expenses | 21.58 | 40.48 | 18.88 | 20.61 | 3.05 | 1.7 |
Current Portion of Leases | 2.73 | 2.71 | 3.83 | 3.19 | - | - |
Other Current Liabilities | - | 0 | - | - | 8.22 | 6.38 |
Total Current Liabilities | 31.4 | 57.94 | 35.46 | 31.5 | 18.31 | 12.95 |
Long-Term Leases | 3.48 | 4.74 | 8.35 | 8.84 | - | - |
Other Long-Term Liabilities | 0 | - | - | - | 0 | -0 |
Total Liabilities | 34.88 | 62.68 | 43.8 | 40.35 | 18.31 | 12.95 |
Common Stock | 9.77 | 9.22 | 1.94 | 1.94 | 1.94 | 1.43 |
Additional Paid-In Capital | 736.03 | 726.28 | 538.15 | 537.65 | 537.4 | 284.48 |
Retained Earnings | -687.44 | -636.76 | -496.56 | -353.08 | -240.16 | -159.87 |
Comprehensive Income & Other | 11.09 | 9.6 | 11.39 | 7.31 | - | - |
Shareholders' Equity | 69.46 | 108.33 | 54.93 | 193.82 | 299.18 | 126.04 |
Total Liabilities & Equity | 104.34 | 171.02 | 98.73 | 234.16 | 317.5 | 138.99 |
Total Debt | 6.21 | 7.45 | 12.17 | 12.03 | - | - |
Net Cash (Debt) | 69.17 | 126.22 | 17.92 | 183.99 | 292.03 | 113.3 |
Net Cash Growth | 285.96% | 604.25% | -90.26% | -37.00% | 157.76% | -4.26% |
Net Cash Per Share | 54.25 | 136.83 | 92.17 | 948.73 | 1469.46 | 792.06 |
Filing Date Shares Outstanding | 0.98 | 0.92 | 0.19 | 0.19 | 0.19 | 0.14 |
Total Common Shares Outstanding | 0.98 | 0.92 | 0.19 | 0.19 | 0.19 | 0.14 |
Working Capital | 50.42 | 86.36 | 22.47 | 181.21 | 288.85 | 113.01 |
Book Value Per Share | 71.06 | 117.44 | 282.50 | 999.42 | 1543.13 | 880.51 |
Tangible Book Value | 69.46 | 108.33 | 54.93 | 193.82 | 299.18 | 126.04 |
Tangible Book Value Per Share | 71.06 | 117.44 | 282.50 | 999.42 | 1543.13 | 880.51 |
Land | - | 34.96 | 33.12 | 13.24 | - | - |
Machinery | - | 27.26 | 28.07 | 21.11 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.